Present status and problems of diagnosis and treatment of tuberculosis in children

doi:10.3969/j.issn.1000-6621.2018.09.002

Abstract

Abstract:

Tuberculosis (TB) remains a global public health problem. Despite substantial progress on the dia-gnosis and treatment of this disease duing to the global commitment to TB, it is still far from goals of ending TB and no death in childhood TB. This article reviewed TB epidemic data, problems and the trends of TB diagnosis and treatment of children in our contry and worldwide.

Key words: Child, Tuberculosis, Diagnostic techniques and procedures, Drug therapy, combination, Comment

Lin SUN,A-dong SHEN. Present status and problems of diagnosis and treatment of tuberculosis in children[J]. Chinese Journal of Antituberculosis, 2018, 40(9): 912-916. doi: 10.3969/j.issn.1000-6621.2018.09.002

References 31

[1]	World Health Organization. Global tuberculosis report 2017. Geneva: World Health Organization, 2017.
[2]	World Health Organization. Roadmap for childhood tuberculosis: toward zero deaths. Geneva: World Health Organization, 2013.
[3]	World Health Organization. The end TB strateny: global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization, 2015.
[4]	Graham SM, Donald PR . Death and disability:the outcomes of tuberculous meningitis. Lancet Infect Dis, 2014,14(10):902-904. doi: 10.1016/S1473-3099(14)70872-2 URL pmid: 25108336
[5]	Graham SM, Sismanidis C, Menzies HJ , et al. Importance of tuberculosis control to address child survival. Lancet, 2014,383(9928):1605-1607. doi: 10.1016/S0140-6736(14)60420-7 URL pmid: 5503686
[6]	World Health Organization. Global tuberculosis report 2012. Geneva: World Health Organization, 2012.
[7]	Jenkins HE, Tolman AW, Yuen CM , et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet, 2014,383(9928):1572-1579. doi: 10.1016/S0140-6736(14)60195-1 URL
[8]	World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization, 2015.
[9]	全国结核病流行病学抽样调查技术指导组. 第四次全国结核病流行病学抽样调查报告. 中华结核和呼吸杂志, 2002,25(1):3-7. doi: 10.3760/j:issn:1001-0939.2002.01.002 URL
[10]	李亮, 端木宏谨 . 1979—2000年四次全国儿童结核病流行病学抽样调查分析. 中华医学杂志, 2004,84(20):1678-1680.
[11]	刘二勇, 马艳, 李涛 , 等. 全国14岁以下儿童肺结核疫情特征分析. 中国防痨杂志, 2014,36(12):1015-1020. doi: 10.3969/j.issn.1000-6621.2014.12.004 URL
[12]	World Bank . World development indicators 2013: population dynamics. Washington: World Bank, 2013: 8.
[13]	Jiao WW, Liu ZG, Han R , et al. Prevalence of drug resistant Mycobacterium tuberculosis among children in China. Tuberculosis (Edinb), 2015,95(3):315-320. doi: 10.1016/j.tube.2015.02.041 URL pmid: 25814302
[14]	Yin QQ, Jiao WW, Han R , et al. Rapid diagnosis of childhood pulmonary tuberculosis by Xpert MTB/RIF assay using bronchoalveolar lavage fluid. Biomed Res Int, 2014: 310194.
[15]	Dodd PJ, Gardiner E, Coghlan R , et al. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical mo-delling study. Lancet Glob Health, 2014,2(8):e453-459. doi: 10.1016/S2214-109X(14)70245-1 URL pmid: 25103518
[16]	World Health Organization. Global tuberculosis control: WHO report 2016. Geneva: World Health Organization, 2016. doi: 10.1111/j.1753-6405.2012.00928.x URL
[17]	World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization, 2015. doi: 10.1136/thoraxjnl-2012-201587 URL pmid: 25973515
[18]	Frieden T, Sterling T, Munsiff S , et al. Tuberculosis. Lancet, 2003,362:887-899. doi: 10.1016/S0140-6736(03)14333-4 URL
[19]	Chen R, Wang J, Zhang Y , et al. Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity. Arch Toxicol, 2015,89(6):883-897. doi: 10.1007/s00204-015-1473-1 URL
[20]	Luzzati R, Migliori GB, Zignol M , et al. Children under 5 years are at risk for tuberculosis after an occasional contact with highly contagious patients: an out-patient outbreak from a smear positive health care worker. Eur Respir J, 2017, 50(5). pii: 1701414. doi: 10.1183/13993003.01414-2017 URL
[21]	World Health Organization. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. Geneva: World Health Organization, 2012.
[22]	Carvalho I, Goletti D, Manga S , et al. Managing latent tuberculosis infection and tuberculosis in children. Pulmonology, 2018,24(2):106-114. doi: 10.1016/j.rppnen.2017.10.007 URL pmid: 29502937
[23]	World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organization, 2014. URL pmid: 17131777
[24]	World Health Organization. The use of loop-mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance. Geneva: World Health Organization, 2016.
[25]	World Health Organization. The use of molecular line probe assays for the detection of resistance to isoniazid and rifam-picin. Geneva: World Health Organization, 2016.
[26]	World Health Organization. The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs: policy guidance. Geneva: World Health Organization, 2016.
[27]	Nicol MP, Gnanashanmugam D, Browning R , et al. A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis. Clin Infect Dis, 2015,61Suppl 3: S164-172. doi: 10.1093/cid/civ613 URL pmid: 26409279
[28]	Deng J, Bi L, Zhou L , et al. Mycobacterium tuberculosis proteome microarray for global studies of protein function and immunogenicity. Cell Rep, 2014,9(6):2317-2329. doi: 10.1016/j.celrep.2014.11.023 URL
[29]	Liu C, Lyon CJ, Bu Y , et al. Clinical Evaluation of a Blood Assay to Diagnose Paucibacillary Tuberculosis Via Bacterial Antigens. Clin Chem, 2018,64(5):791-800. doi: 10.1373/clinchem.2017.273698 URL
[30]	World Health Organization, United Nations International Children’s Emergency Fund. Statement on the use of child-friendly fixed-dose combinations for the treatment of TB in children. Geneva: World Health Organization, 2017.
[31]	World Health Organization. The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance. Geneva: World Health Organization, 2016.